[Is small cell lung cancer an orphan disease?].
Pujol
J L
JL
Service de Pneumologie-Phtisiologie, Clinique des maladies respiratoires, Hopital Arnaud-de-Villeneuve, 34295 Montpellier 5, France.
D000284:Administration, Oral; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D008297:Male; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012737:Sex Factors; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use; D019772:Topotecan / Q000008:administration & dosage / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D013792:Thalidomide; D014750:Vincristine; D000077146:Irinotecan; D019772:Topotecan; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D002166:Camptothecin